Your Location：
Home >
Browse articles >
Predicting Hepatic Fibrosis Risk in Wilson's Disease： Development and Validation of Prognostic Model Integrating TCM Syndromes and Modern Biomarkers
Predicting Hepatic Fibrosis Risk in Wilson's Disease： Development and Validation of Prognostic Model Integrating TCM Syndromes and Modern Biomarkers
Enhanced Publication- Chinese Journal of Experimental Traditional Medical Formulae Vol. 32, Issue 18, Pages: 197-207(2026)
DOI： 10.13422/j.cnki.syfjx.20260794
Revised：2025-11-30 ，
Accepted：23 January 2026
Scan QR Code
Full Text(HTML)
Figs( 7 ) Tabs( 2 )
References
Publication Info
Metrics
49
Views
27
Downloads
0
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Mechanism of Qinggan Jianpi Huoxue Prescription Against Hepatic Fibrosis via FoxO1 Mediated Regulation of Glycolytic Metabolic Reprogramming of Hepatic Stellate Cells
Guizhi Fulingwan Alleviate Hepatic Fibrosis by Modulating mtDNA/NLRP3/Caspase-1/GSDMD Signaling Pathway
Staged Treatment of Hepatic Fibrosis Based on Correlation Between "Collaterals and Vascular System" and Theory of "Hepatic Collateral Disease"
Investigating Molecular Mechanisms of Qijia Rougan Prescription and Its Key Effect or Ingredients Against Hepatic Fibrosis Based on Macrophage M2 Polarization
Chinese Medicine Regulates Nrf2 Signaling Pathway for Treating Hepatic Fibrosis： A Review
Related Author
PAN Fuzhen
ZHU Meng
SHI Chuanjian
XU Shiqiang
LIU Ding
ZHANG Jinfang
TANG Yu
YANG Xuli
Related Institution
Shenzhen Hospital （Futian） of Guangzhou University of Chinese Medicine
School of Basic Medical Sciences，Zhejiang Chinese Medical University
Jiangmen Wuyi Hospital of Traditional Chinese Medicine
Chengdu University of Traditional Chinese Medicine （TCM）
Sichuan Lezhi County Hospital of TCM
Intro
Map
Chat
